Sumitomo Mitsui Trust Group Inc. Sells 33,053 Shares of Henry Schein, Inc. (NASDAQ:HSIC)

Sumitomo Mitsui Trust Group Inc. reduced its holdings in Henry Schein, Inc. (NASDAQ:HSIC - Free Report) by 10.7% during the 3rd quarter, according to the company in its most recent disclosure with the SEC. The fund owned 275,630 shares of the company's stock after selling 33,053 shares during the quarter. Sumitomo Mitsui Trust Group Inc. owned about 0.22% of Henry Schein worth $20,093,000 as of its most recent filing with the SEC.

Several other hedge funds and other institutional investors also recently made changes to their positions in the business. UniSuper Management Pty Ltd lifted its stake in shares of Henry Schein by 611.8% in the first quarter. UniSuper Management Pty Ltd now owns 13,695 shares of the company's stock valued at $1,034,000 after buying an additional 11,771 shares during the period. Thompson Siegel & Walmsley LLC bought a new stake in shares of Henry Schein in the second quarter valued at about $46,683,000. Vanguard Group Inc. lifted its stake in shares of Henry Schein by 1.7% in the first quarter. Vanguard Group Inc. now owns 15,432,001 shares of the company's stock valued at $1,165,425,000 after buying an additional 260,537 shares during the period. SG Americas Securities LLC lifted its stake in shares of Henry Schein by 1,622.3% in the third quarter. SG Americas Securities LLC now owns 458,828 shares of the company's stock valued at $33,449,000 after buying an additional 432,187 shares during the period. Finally, Sei Investments Co. lifted its stake in shares of Henry Schein by 8.0% in the second quarter. Sei Investments Co. now owns 420,957 shares of the company's stock valued at $26,983,000 after buying an additional 31,168 shares during the period. 96.62% of the stock is owned by institutional investors and hedge funds.

Insider Activity at Henry Schein

In other news, SVP Lorelei Mcglynn sold 21,035 shares of the business's stock in a transaction on Friday, September 6th. The shares were sold at an average price of $69.30, for a total value of $1,457,725.50. Following the completion of the transaction, the senior vice president now owns 71,833 shares of the company's stock, valued at $4,978,026.90. The trade was a 22.65 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. 1.14% of the stock is currently owned by company insiders.

Analyst Ratings Changes

A number of brokerages have commented on HSIC. Robert W. Baird cut their price target on shares of Henry Schein from $92.00 to $82.00 and set an "outperform" rating for the company in a research note on Wednesday, August 7th. Barrington Research restated an "outperform" rating and set a $82.00 price target on shares of Henry Schein in a research note on Wednesday, November 6th. Evercore ISI raised their price target on shares of Henry Schein from $70.00 to $74.00 and gave the stock an "in-line" rating in a research note on Tuesday, October 8th. JPMorgan Chase & Co. cut their price target on shares of Henry Schein from $88.00 to $80.00 and set an "overweight" rating for the company in a research note on Monday, August 12th. Finally, StockNews.com upgraded shares of Henry Schein from a "sell" rating to a "hold" rating in a research note on Thursday, November 7th. Six investment analysts have rated the stock with a hold rating, five have issued a buy rating and one has given a strong buy rating to the stock. According to data from MarketBeat, the company has an average rating of "Moderate Buy" and an average price target of $78.89.

Henry Schein Price Performance

Shares of NASDAQ:HSIC traded up $5.13 during trading on Monday, reaching $73.89. The stock had a trading volume of 3,564,726 shares, compared to its average volume of 1,367,991. The company has a debt-to-equity ratio of 0.46, a current ratio of 1.42 and a quick ratio of 0.82. The stock has a market capitalization of $9.21 billion, a PE ratio of 30.41, a P/E/G ratio of 1.97 and a beta of 0.87. The business's 50-day moving average price is $70.40 and its 200 day moving average price is $69.61. Henry Schein, Inc. has a 52 week low of $63.67 and a 52 week high of $82.63.

Henry Schein (NASDAQ:HSIC - Get Free Report) last issued its quarterly earnings results on Tuesday, November 5th. The company reported $1.22 earnings per share for the quarter, beating analysts' consensus estimates of $1.17 by $0.05. The business had revenue of $3.17 billion during the quarter, compared to analyst estimates of $3.24 billion. Henry Schein had a net margin of 2.51% and a return on equity of 12.90%. Henry Schein's revenue for the quarter was up .4% compared to the same quarter last year. During the same quarter last year, the business posted $1.32 earnings per share. As a group, equities analysts predict that Henry Schein, Inc. will post 4.78 earnings per share for the current year.

Henry Schein Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.